UA97785C2 - Иммуногенные композиции, которые содержат lawsonia intracellularis - Google Patents

Иммуногенные композиции, которые содержат lawsonia intracellularis

Info

Publication number
UA97785C2
UA97785C2 UAA200711236A UAA200711236A UA97785C2 UA 97785 C2 UA97785 C2 UA 97785C2 UA A200711236 A UAA200711236 A UA A200711236A UA A200711236 A UAA200711236 A UA A200711236A UA 97785 C2 UA97785 C2 UA 97785C2
Authority
UA
Ukraine
Prior art keywords
immunogenic compositions
lawsonia intracellularis
immunological
effective
lessening
Prior art date
Application number
UAA200711236A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джереми Кроулл
Майк РУФ
Original Assignee
Берингер Ингельхайм Ветмедика, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Ветмедика, Инк. filed Critical Берингер Ингельхайм Ветмедика, Инк.
Priority claimed from PCT/US2006/009618 external-priority patent/WO2006099561A1/en
Publication of UA97785C2 publication Critical patent/UA97785C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

В заявке описаны комбинированные вакцины, которые содержат иммунологический агент, имеющий эффективность относительно снижения заболеваемости или уменьшение серьезности ПЭС, которая вызывается L. intracellularis, и один или несколько иммунологически активных компонентов, которые имеют эффективность относительно лечения и/или профилактики, по крайней мере, одного другого заболевания, которое вызывается болезнетворным для свиней микроорганизмом. Также описан набор, который содержит иммунологический агент, который имеет эффективность относительно снижения заболеваемости или уменьшения серьезности ПЭС, которая вызывается L. intracellularis, и один или несколько иммунологически активных компонентов, которые имеют эффективность относительно лечения и/или профилактики, по крайней мере, одного другого заболевания, которое вызывается болезнетворным
UAA200711236A 2005-03-14 2006-03-14 Иммуногенные композиции, которые содержат lawsonia intracellularis UA97785C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66135205P 2005-03-14 2005-03-14
PCT/US2006/009618 WO2006099561A1 (en) 2005-03-14 2006-03-14 Immunogenic compositions comprising lawsonia intracellularis

Publications (1)

Publication Number Publication Date
UA97785C2 true UA97785C2 (ru) 2012-03-26

Family

ID=38687232

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200711236A UA97785C2 (ru) 2005-03-14 2006-03-14 Иммуногенные композиции, которые содержат lawsonia intracellularis
UAA201111797A UA102145C2 (ru) 2005-03-14 2006-03-14 Иммуногенная композиция, которая содержит lawsonia intracellularis

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA201111797A UA102145C2 (ru) 2005-03-14 2006-03-14 Иммуногенная композиция, которая содержит lawsonia intracellularis

Country Status (2)

Country Link
RU (1) RU2443430C2 (ru)
UA (2) UA97785C2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2629399C1 (ru) * 2016-08-08 2017-08-29 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ профилактики африканской чумы свиней
WO2020099293A1 (en) 2018-11-12 2020-05-22 Intervet International B.V. Novel porcine rotavirus

Also Published As

Publication number Publication date
RU2007137984A (ru) 2009-04-20
RU2443430C2 (ru) 2012-02-27
UA102145C2 (ru) 2013-06-10

Similar Documents

Publication Publication Date Title
EP3354279A3 (en) Immunogenic compositions comprising lawsonia intracellularis
WO2008073464A3 (en) Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PH12014502525A1 (en) Multivalent pcv2 immunogenic compositions and methods of producing such compositions
MY152149A (en) Prevention and treatment of sub-clinical pcvd
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2010025109A8 (en) Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
WO2006027685A3 (en) Glycosylceramide adjuvant for saccharide antigens
UA95458C2 (ru) Вакцина против pcv-2 у mda-положительных поросят
TW200511941A (en) Method of reducing unpleasant taste and/or unpleasant odor
WO2009030684A3 (en) Reduction of concomitant infections in pigs by the use of pcv2 antigen
MX2010007815A (es) Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
PL2291195T5 (pl) Szczepionka do ochrony przeciw Lawsonia Intracellularis, Mycoplasma Hyopneumoniae i Cirkowirusowi świń
NZ621834A (en) Novel adjuvant compositions
WO2007094893A3 (en) Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
MXPA06005639A (es) Adyuvante antimicrobiano.
MX2009006541A (es) Tratamiento de prdc en cerdos.
TWI319708B (en) Methods and compositions for altering cell fuction
MX2010003452A (es) Composiciones de tratamiento para el cabello.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
TW200603825A (en) Prrsv subunit vaccines
HRP20090511T1 (en) Compositions for vaginal use
WO2007142984A3 (en) Nutritional formulations and associated methods
MX2007005968A (es) Cepas y composiciones del virus del sindrome reproductivo y respiratorio porcino.
UA97785C2 (ru) Иммуногенные композиции, которые содержат lawsonia intracellularis